|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 48/00 | |
| A61K 38/17 | |||
| A61K 38/46 | |||
| A61P 27/02 | |||
| C07K 14/47 |
| (11) | Patento numeris | 2872183 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13816245.8 |
| Europos patento paraiškos padavimo data | 2013-01-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-05-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/022628 |
| Data | 2013-01-23 |
| (87) | Numeris | WO 2014/011210 |
| Data | 2014-01-16 |
| (30) | Numeris | Data | Šalis |
| 201261670355 P | 2012-07-11 | US |
| (72) |
BELTRAN, William, A., US
AGUIRRE, Gustavo, D., US
JACOBSON, Samuel, G., US
CIDECIYAN, Artur, V., US
LEWIN, Alfred, S., US
BOYE, Sanford, L., US
HAUSWIRTH, William, W., US
DENG, Wen-Tao, US
|
| (73) |
The Trustees of The University of Pennsylvania,
3160 Chestnut Street Suite 200, Philadelphia, PA 19104,
US
University of Florida Research Foundation, Inc., 223 Grinter Hall, Gainesville, FL 32611, US |
| (54) | AAV-MEDIATED GENE THERAPY FOR RPGR X-LINKED RETINAL DEGENERATION |
| AAV-MEDIATED GENE THERAPY FOR RPGR X-LINKED RETINAL DEGENERATION |